Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner.

Høglund RA, Torsetnes SB, Lossius A, Bogen B, Homan EJ, Bremel R, Holmøy T.

Int J Mol Sci. 2019 Sep 29;20(19). pii: E4843. doi: 10.3390/ijms20194843.

2.

CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models.

Bogen B, Fauskanger M, Haabeth OA, Tveita A.

Cancer Immunol Immunother. 2019 Nov;68(11):1865-1873. doi: 10.1007/s00262-019-02374-0. Epub 2019 Aug 26. Review.

PMID:
31448380
3.

Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses.

Tesfaye DY, Gudjonsson A, Bogen B, Fossum E.

Front Immunol. 2019 Jul 4;10:1529. doi: 10.3389/fimmu.2019.01529. eCollection 2019. Review.

4.

Two-year changes in gait variability in community-living older adults.

Bogen B, Aaslund MK, Ranhoff AH, Moe-Nilssen R.

Gait Posture. 2019 Jul;72:142-147. doi: 10.1016/j.gaitpost.2019.06.005. Epub 2019 Jun 7.

5.

Endocytosis Deficient Murine Xcl1-Fusion Vaccine Enhances Protective Antibody Responses in Mice.

Gudjonsson A, Andersen TK, Sundvold-Gjerstad V, Bogen B, Fossum E.

Front Immunol. 2019 May 17;10:1086. doi: 10.3389/fimmu.2019.01086. eCollection 2019.

6.

A role for IL-34 in osteolytic disease of multiple myeloma.

Baghdadi M, Ishikawa K, Nakanishi S, Murata T, Umeyama Y, Kobayashi T, Kameda Y, Endo H, Wada H, Bogen B, Yamamoto S, Yamaguchi K, Kasahara I, Iwasaki H, Takahata M, Ibata M, Takahashi S, Goto H, Teshima T, Seino KI.

Blood Adv. 2019 Feb 26;3(4):541-551. doi: 10.1182/bloodadvances.2018020008.

7.

Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules.

Andersen TK, Huszthy PC, Gopalakrishnan RP, Jacobsen JT, Fauskanger M, Tveita AA, Grødeland G, Bogen B.

NPJ Vaccines. 2019 Feb 11;4:9. doi: 10.1038/s41541-019-0101-0. eCollection 2019.

8.

Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site.

Lysén A, Braathen R, Gudjonsson A, Tesfaye DY, Bogen B, Fossum E.

Sci Rep. 2019 Feb 12;9(1):1820. doi: 10.1038/s41598-018-38080-7.

9.

Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.

Mooij P, Grødeland G, Koopman G, Andersen TK, Mortier D, Nieuwenhuis IG, Verschoor EJ, Fagrouch Z, Bogers WM, Bogen B.

Vaccine. 2019 Feb 4;37(6):817-826. doi: 10.1016/j.vaccine.2018.12.049. Epub 2019 Jan 9.

10.

Subungual and ungual scabies: avoiding severe presentation in high-risk patients.

Last O, Reckhow J, Bogen B, Rozenblat M.

BMJ Case Rep. 2018 Dec 3;11(1). pii: bcr-2018-225623. doi: 10.1136/bcr-2018-225623.

PMID:
30567157
11.

Polarity of CD4+ T cells towards the antigen presenting cell is regulated by the Lck adapter TSAd.

Abrahamsen G, Sundvold-Gjerstad V, Habtamu M, Bogen B, Spurkland A.

Sci Rep. 2018 Sep 6;8(1):13319. doi: 10.1038/s41598-018-31510-6.

12.

The impact of wearable motion sensing technology on physical activity in older adults.

Cooper C, Gross A, Brinkman C, Pope R, Allen K, Hastings S, Bogen BE, Goode AP.

Exp Gerontol. 2018 Oct 2;112:9-19. doi: 10.1016/j.exger.2018.08.002. Epub 2018 Aug 10.

13.

Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity.

Fauskanger M, Haabeth OAW, Skjeldal FM, Bogen B, Tveita AA.

Front Immunol. 2018 Jul 23;9:1684. doi: 10.3389/fimmu.2018.01684. eCollection 2018.

14.

CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs.

Haabeth OAW, Fauskanger M, Manzke M, Lundin KU, Corthay A, Bogen B, Tveita AA.

Cancer Res. 2018 Aug 15;78(16):4573-4585. doi: 10.1158/0008-5472.CAN-17-2426. Epub 2018 May 11.

15.

Does sarcopenia predict change in mobility after hip fracture? a multicenter observational study with one-year follow-up.

Steihaug OM, Gjesdal CG, Bogen B, Kristoffersen MH, Lien G, Hufthammer KO, Ranhoff AH.

BMC Geriatr. 2018 Mar 5;18(1):65. doi: 10.1186/s12877-018-0755-x.

16.

The walk ratio: Investigation of invariance across walking conditions and gender in community-dwelling older people.

Bogen B, Moe-Nilssen R, Ranhoff AH, Aaslund MK.

Gait Posture. 2018 Mar;61:479-482. doi: 10.1016/j.gaitpost.2018.02.019. Epub 2018 Feb 21.

PMID:
29494821
17.

Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza.

Anderson AM, Baranowska-Hustad M, Braathen R, Grodeland G, Bogen B.

J Immunol. 2018 Mar 15;200(6):2057-2066. doi: 10.4049/jimmunol.1701088. Epub 2018 Feb 2.

18.

The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules.

Braathen R, Spång HCL, Lindeberg MM, Fossum E, Grødeland G, Fredriksen AB, Bogen B.

Immunohorizons. 2018 Jan 18;2(1):38-53. doi: 10.4049/immunohorizons.1700038.

PMID:
31022690
19.

In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis.

Høglund RA, Lossius A, Johansen JN, Homan J, Benth JŠ, Robins H, Bogen B, Bremel RD, Holmøy T.

Front Immunol. 2017 Oct 2;8:1255. doi: 10.3389/fimmu.2017.01255. eCollection 2017.

20.

A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.

Andersen TK, Zhou F, Cox R, Bogen B, Grødeland G.

J Virol. 2017 Nov 14;91(23). pii: e01340-17. doi: 10.1128/JVI.01340-17. Print 2017 Dec 1.

21.

Sarcopenia in patients with hip fracture: A multicenter cross-sectional study.

Steihaug OM, Gjesdal CG, Bogen B, Kristoffersen MH, Lien G, Ranhoff AH.

PLoS One. 2017 Sep 13;12(9):e0184780. doi: 10.1371/journal.pone.0184780. eCollection 2017.

22.

A longitudinal study investigating how stroke severity, disability, and physical function the first week post-stroke are associated with walking speed six months post-stroke.

Aaslund MK, Moe-Nilssen R, Gjelsvik BB, Bogen B, Næss H, Hofstad H, Skouen JS.

Physiother Theory Pract. 2017 Dec;33(12):932-942. doi: 10.1080/09593985.2017.1360424. Epub 2017 Aug 17.

PMID:
28816573
23.

The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin.

Deloizy C, Fossum E, Barnier-Quer C, Urien C, Chrun T, Duval A, Codjovi M, Bouguyon E, Maisonnasse P, Hervé PL, Barc C, Boulesteix O, Pezant J, Chevalier C, Collin N, Dalod M, Bogen B, Bertho N, Schwartz-Cornil I.

Sci Rep. 2017 Aug 9;7(1):7639. doi: 10.1038/s41598-017-07372-9.

24.

The Association between Daily Walking Behavior and Self-Reported Physical Function in Community-Dwelling Older Adults.

Bogen B, Aaslund MK, Ranhoff AH, Taraldsen K, Moe-Nilssen R.

J Frailty Aging. 2017;6(2):88-90. doi: 10.14283/jfa.2017.12.

PMID:
28555709
25.

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor.

Lilly CL, Villa NY, Lemos de Matos A, Ali HM, Dhillon JS, Hofland T, Rahman MM, Chan W, Bogen B, Cogle C, McFadden G.

Mol Ther Oncolytics. 2016 Dec 14;4:31-40. doi: 10.1016/j.omto.2016.12.002. eCollection 2017 Mar 17.

26.

Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model.

Park BM, Kim EJ, Nam HJ, Zhang D, Bae CH, Kang M, Kim H, Lee W, Bogen B, Lim SK.

Yonsei Med J. 2017 May;58(3):505-513. doi: 10.3349/ymj.2017.58.3.505.

27.

Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice.

Wang D, Fløisand Y, Myklebust CV, Bürgler S, Parente-Ribes A, Hofgaard PO, Bogen B, Taskén K, Tjønnfjord GE, Schjesvold F, Dalgaard J, Tveita A, Munthe LA.

Leukemia. 2017 Oct;31(10):2114-2121. doi: 10.1038/leu.2017.69. Epub 2017 Feb 24.

PMID:
28232741
28.

Targeting Influenza Virus Hemagglutinin to Xcr1+ Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody Responses.

Gudjonsson A, Lysén A, Balan S, Sundvold-Gjerstad V, Arnold-Schrauf C, Richter L, Bækkevold ES, Dalod M, Bogen B, Fossum E.

J Immunol. 2017 Apr 1;198(7):2785-2795. doi: 10.4049/jimmunol.1601881. Epub 2017 Feb 22.

29.

Higher Drop in Speed during a Repeated Sprint Test in Soccer Players Reporting Former Hamstring Strain Injury.

Røksund OD, Kristoffersen M, Bogen BE, Wisnes A, Engeseth MS, Nilsen AK, Iversen VV, Mæland S, Gundersen H.

Front Physiol. 2017 Jan 27;8:25. doi: 10.3389/fphys.2017.00025. eCollection 2017.

30.

Chronic urticaria and atopic disorders: a cross-sectional study of 11 271 patients.

Shalom G, Magen E, Dreiher J, Freud T, Bogen B, Comaneshter D, Vardy DA, Khoury R, Agmon-Levin N, Cohen AD.

Br J Dermatol. 2017 Oct;177(4):e96-e97. doi: 10.1111/bjd.15347. Epub 2017 Aug 15. No abstract available.

PMID:
28129676
31.

Unlocking bat immunology: establishment of Pteropus alecto bone marrow-derived dendritic cells and macrophages.

Zhou P, Chionh YT, Irac SE, Ahn M, Jia Ng JH, Fossum E, Bogen B, Ginhoux F, Irving AT, Dutertre CA, Wang LF.

Sci Rep. 2016 Dec 9;6:38597. doi: 10.1038/srep38597.

32.

Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice.

Bartee E, Bartee MY, Bogen B, Yu XZ.

Mol Ther Oncolytics. 2016 Dec 7;3:16032. eCollection 2016.

33.

Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.

Grodeland G, Fredriksen AB, Løset GÅ, Vikse E, Fugger L, Bogen B.

J Immunol. 2016 Nov 1;197(9):3575-3585. Epub 2016 Sep 26.

34.

Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species.

Guilliams M, Dutertre CA, Scott CL, McGovern N, Sichien D, Chakarov S, Van Gassen S, Chen J, Poidinger M, De Prijck S, Tavernier SJ, Low I, Irac SE, Mattar CN, Sumatoh HR, Low GHL, Chung TJK, Chan DKH, Tan KK, Hon TLK, Fossum E, Bogen B, Choolani M, Chan JKY, Larbi A, Luche H, Henri S, Saeys Y, Newell EW, Lambrecht BN, Malissen B, Ginhoux F.

Immunity. 2016 Sep 20;45(3):669-684. doi: 10.1016/j.immuni.2016.08.015. Epub 2016 Sep 13.

35.

Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response.

Lorvik KB, Hammarström C, Fauskanger M, Haabeth OA, Zangani M, Haraldsen G, Bogen B, Corthay A.

Cancer Res. 2016 Dec 1;76(23):6864-6876. Epub 2016 Sep 12.

36.

Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display.

Tveita A, Fauskanger M, Bogen B, Haabeth OA.

Oncotarget. 2016 Oct 11;7(41):67175-67182. doi: 10.18632/oncotarget.11946.

37.

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.

Lambert L, Kinnear E, McDonald JU, Grodeland G, Bogen B, Stubsrud E, Lindeberg MM, Fredriksen AB, Tregoning JS.

Front Immunol. 2016 Aug 23;7:321. doi: 10.3389/fimmu.2016.00321. eCollection 2016.

38.

Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery.

Ardouin L, Luche H, Chelbi R, Carpentier S, Shawket A, Montanana Sanchis F, Santa Maria C, Grenot P, Alexandre Y, Grégoire C, Fries A, Vu Manh TP, Tamoutounour S, Crozat K, Tomasello E, Jorquera A, Fossum E, Bogen B, Azukizawa H, Bajenoff M, Henri S, Dalod M, Malissen B.

Immunity. 2016 Aug 16;45(2):305-18. doi: 10.1016/j.immuni.2016.07.019.

39.

Identifying Low Muscle Mass in Patients with Hip Fracture: Validation of Biolectrical Impedance Analysis and Anthropometry Compared to Dual Energy X-ray Absorptiometry.

Steihaug OM, Gjesdal CG, Bogen B, Ranhoff AH.

J Nutr Health Aging. 2016;20(7):685-90. doi: 10.1007/s12603-016-0686-1.

PMID:
27499300
40.

Expanding the tools for identifying mononuclear phagocyte subsets in swine: Reagents to porcine CD11c and XCR1.

Deloizy C, Bouguyon E, Fossum E, Sebo P, Osicka R, Bole A, Pierres M, Biacchesi S, Dalod M, Bogen B, Bertho N, Schwartz-Cornil I.

Dev Comp Immunol. 2016 Dec;65:31-40. doi: 10.1016/j.dci.2016.06.015. Epub 2016 Jun 21.

PMID:
27345169
41.

Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity.

Andersen AN, Landsverk OJ, Simonsen A, Bogen B, Corthay A, Øynebråten I.

Front Immunol. 2016 May 10;7:167. doi: 10.3389/fimmu.2016.00167. eCollection 2016.

42.

Correlation between the Gait Deviation Index and gross motor function (GMFCS level) in children with cerebral palsy.

Malt MA, Aarli Å, Bogen B, Fevang JM.

J Child Orthop. 2016 Jun;10(3):261-6. doi: 10.1007/s11832-016-0738-4. Epub 2016 May 13.

43.

Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells.

Haabeth OA, Lorvik KB, Yagita H, Bogen B, Corthay A.

Oncoimmunology. 2015 Jul 25;5(1):e1039763. eCollection 2016.

44.

IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration.

Kulkarni U, Karsten CM, Kohler T, Hammerschmidt S, Bommert K, Tiburzy B, Meng L, Thieme L, Recke A, Ludwig RJ, Pollok K, Kalies K, Bogen B, Boettcher M, Kamradt T, Hauser AE, Langer C, Huber-Lang M, Finkelman FD, Köhl J, Wong DM, Manz RA.

J Allergy Clin Immunol. 2016 May;137(5):1487-1497.e6. doi: 10.1016/j.jaci.2015.10.018. Epub 2015 Dec 2.

PMID:
26653800
45.

Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells.

Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA.

Haematologica. 2016 Feb;101(2):e59-62. doi: 10.3324/haematol.2015.135590. Epub 2015 Nov 20. No abstract available.

46.

Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.

Kikuchi J, Koyama D, Wada T, Izumi T, Hofgaard PO, Bogen B, Furukawa Y.

J Clin Invest. 2015 Oct 26;125(12):4375-90. doi: 10.1172/JCI80325.

47.

Idiotype-specific CD4(+) T cells eradicate disseminated myeloma.

Haabeth OA, Tveita A, Fauskanger M, Hennig K, Hofgaard PO, Bogen B.

Leukemia. 2016 May;30(5):1216-20. doi: 10.1038/leu.2015.278. Epub 2015 Oct 9. No abstract available.

PMID:
26449664
48.

Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.

Baranowska M, Hauge AG, Hoornaert C, Bogen B, Grødeland G.

Vaccine. 2015 Dec 8;33(49):6988-96. doi: 10.1016/j.vaccine.2015.08.094. Epub 2015 Sep 19.

49.

Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides-As Antigens for Th Cells.

Aas-Hanssen K, Thompson KM, Bogen B, Munthe LA.

Front Immunol. 2015 Jul 28;6:382. doi: 10.3389/fimmu.2015.00382. eCollection 2015. Review.

50.

Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines.

Grødeland G, Fossum E, Bogen B.

Front Immunol. 2015 Jul 20;6:367. doi: 10.3389/fimmu.2015.00367. eCollection 2015. Review.

Supplemental Content

Support Center